A Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of T3D-959 in Subjects with Mild to Moderate Alzheimer's Disease
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
T3D Therapeutics, Inc.
Start Date
November 6, 2018
End Date
June 30, 2019
Administered By
Duke Clinical Research Institute
Awarded By
T3D Therapeutics, Inc.
Start Date
November 6, 2018
End Date
June 30, 2019